Marketwatch Citigroup has buy on Biocon, target price Rs 350 Admin December 4, 2019 Citi gave the buy rating after the company and Mylan announced launch of Ogivri in the US. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
